Cite
Baan CC, Balk AH, Mol WM, et al. Anti-CD25 therapy affects the death signals of activated T-cells after clinical heart transplantation. J Heart Lung Transplant. 2001;20(2):220doi: 10.1016/s1053-2498(00)00481-2.
Baan, C. C., Balk, A. H., Mol, W. M., Van Riemsdijk, I. C., De Kuiper, P., Van Gelder, T., Vantrimpont, P. M., Maat, A. P., & Weimar, W. (2001). Anti-CD25 therapy affects the death signals of activated T-cells after clinical heart transplantation. The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation, 20(2), 220. https://doi.org/10.1016/s1053-2498(00)00481-2
Baan, C C., et al. "Anti-CD25 therapy affects the death signals of activated T-cells after clinical heart transplantation." The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation vol. 20,2 (2001): 220. doi: https://doi.org/10.1016/s1053-2498(00)00481-2
Baan CC, Balk AH, Mol WM, Van Riemsdijk IC, De Kuiper P, Van Gelder T, Vantrimpont PM, Maat AP, Weimar W. Anti-CD25 therapy affects the death signals of activated T-cells after clinical heart transplantation. J Heart Lung Transplant. 2001 Feb;20(2):220. doi: 10.1016/s1053-2498(00)00481-2. PMID: 11250408.
Copy
Download .nbib